Mayne Pharma Group Ltd (MAYNF)
4.26
-0.22
(-4.91%)
USD |
OTCM |
May 17, 16:00
Mayne Pharma Group Total Liabilities (Quarterly): 412.10M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 412.10M |
| June 30, 2023 | 405.76M |
| December 31, 2022 | 473.08M |
| June 30, 2022 | 502.73M |
| December 31, 2021 | 521.20M |
| June 30, 2021 | 519.63M |
| December 31, 2020 | 547.79M |
| June 30, 2020 | 537.92M |
| December 31, 2019 | 541.21M |
| June 30, 2019 | 435.79M |
| December 31, 2018 | 503.71M |
| June 30, 2018 | 437.34M |
| December 31, 2017 | 465.54M |
| June 30, 2017 | 462.99M |
| December 31, 2016 | 417.58M |
| June 30, 2016 | 882.07M |
| December 31, 2015 | 181.34M |
| June 30, 2015 | 158.57M |
| Date | Value |
|---|---|
| December 31, 2014 | 114.49M |
| June 30, 2014 | 100.31M |
| December 31, 2013 | 109.54M |
| June 30, 2013 | 104.39M |
| December 31, 2012 | 85.71M |
| June 30, 2012 | 23.41M |
| December 31, 2011 | 27.55M |
| June 30, 2011 | 31.53M |
| December 31, 2010 | 39.90M |
| June 30, 2010 | 38.35M |
| December 31, 2009 | 37.05M |
| June 30, 2009 | 0.2672M |
| December 31, 2008 | 0.1969M |
| June 30, 2008 | 0.244M |
| December 31, 2007 | 0.2827M |
| June 30, 2007 | 0.8444M |
| December 31, 2006 | 0.1441M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
405.76M
Minimum
Jun 2023
547.79M
Maximum
Dec 2020
489.72M
Average
511.18M
Median
Total Liabilities (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | 2.345M |
| Kazia Therapeutics Ltd | 13.02M |
| Immutep Ltd | 9.137M |
| Opthea Ltd | 213.41M |
| Mesoblast Ltd | 167.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 785.30M |
| Shareholders Equity (Quarterly) | 373.20M |
| Debt to Equity Ratio | 0.0668 |
| Current Ratio | 1.608 |
| Net Debt Paydown Yield | 24.51% |